Correlation Between Iovance Biotherapeutics and Amgen

Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Iovance Biotherapeutics and Amgen Inc, you can compare the effects of market volatilities on Iovance Biotherapeutics and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Amgen.

Diversification Opportunities for Iovance Biotherapeutics and Amgen

-0.91

Correlation Coefficient

Iovance Biotherapeutics  Amgen

Pay attention - limited upside

The 3 months correlation between Iovance and Amgen is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Amgen go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and Amgen

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Amgen. In addition to that, Iovance Biotherapeutics is 2.87 times more volatile than Amgen Inc. It trades about -0.24 of its total potential returns per unit of risk. Amgen Inc is currently generating about 0.2 per unit of volatility. If you would invest  25,722  in Amgen Inc on December 28, 2024 and sell it today you would earn a total of  4,855  from holding Amgen Inc or generate 18.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Iovance Biotherapeutics  vs.  Amgen Inc

Iovance Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Amgen Inc

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Amgen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Iovance Biotherapeutics and Amgen

The main advantage of trading using opposite Iovance Biotherapeutics and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.

The idea behind Iovance Biotherapeutics and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.